J Korean Ophthalmol Soc.
2020 Jul;61(7):815-818. 10.3341/jkos.2020.61.7.815.
Recurrent Conjunctival Granuloma Treated with Subconjunctival Bevacizumab
- Affiliations
-
- 1Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
- KMID: 2504323
- DOI: http://doi.org/10.3341/jkos.2020.61.7.815
Abstract
- Purpose
We report a case of recurrent conjunctival granuloma showing complete resolution after bevacizumab injection.
Case summary
A 45-year-old female presented with a mass near right upper punctum for one month. She underwent surgical resection and was diagnosed as the conjunctival granuloma. Thereafter, the granuloma recurred five times. At the last recurrence, bevacizumab was injected into the granuloma and surrounding tissue with surgical resection. There was no recurrence and no side effects for seven months after surgery.
Conclusion
Subconjunctival bevacizumab injection therapy may be a useful treatment in patients with recurrent conjunctival granuloma.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Results After Application of Bevacizumab in Recurrent Pterygium
- A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
- Efficacy and Safety of a Large Conjunctival Autograft for Recurrent Pterygium
- The Effect of Subconjunctival Bevacizumab Injection before Conjunctival Autograft for Pterygium
- Efficacy of Subconjunctival Bevacizumab Injection after Pterygium Excision with Limbal Conjunctival Autograft in Recurred Pterygium
